The Chacruna Institute endorses the Breakthrough Therapies Act introduced by Senators Cory Booker and Rand Paul. Chacruna supports this opportunity to reduce barriers to MDMA and psilocybin-assisted therapy.

A large group of Brazilian scientists carried out the first randomized placebo-controlled trial with ayahuasca in 29 patients with treatment-resistant depression, and the results...

Read Bia Labate's opening remarks for Psychedelic Science 2023 conference in Denver, Colorado, June 2023. She urges businesses, researchers, and clinicians to take reciprocity and community care seriously.

  On January 31, 2018, a very important and delicate court case took place in Amsterdam. It was the appeal court case about the confiscation...

Studies in Psychedelic Justice, a new program offered by Chacruna Institute for Psychedelic Plant Medicines, begins May 3 with the first of three courses (and a one-time workshop) designed to fill what Chacruna identifies as a void in the psychedelic space.

A Canadian company, Filament Health, plans to develop ayahuasca pills. These pills promise to provide a standardized ayahuasca experience, but what does the commodification of ayahuasca mean for ethical consumption. Indigenous peoples with cultural and spiritual connections to ayahuasca need to be given the opportunity to provide full consent.

Webinar May 25th, 20214:30-6:00 PST  Registrations close at noon PST on May 25th IPCI will answer questions about the delicate ecological status of Peyote and how...

  Are you or is someone you know looking for research funding? We are a private non-profit foundation. Our mission is to connect, inspire, and support...

WHO WE ARE: The Chacruna Institute for Psychedelic Plant Medicines, is a 501(c)(3) non-profit organization co-founded by Brazilian anthropologist Dr. Bia Labate and American psychologist...

Pema Sheth is a shamanic practitioner who offers healing circles in Oakland to heal ailments such as PTSD, addiction, and depression. For 20 years,...